Global Precision Medicine IT Solutions for Oncology - Companies to Action, 2017: Early Movers Expect to Facilitate Evidence-Based Cancer Care

Dublin, Jan. 04, 2018 -- The "Global Precision Medicine IT Solutions for Oncology - Companies to Action, 2017" report has been added to Research and Markets' offering.

This report profiles vendors that are offering promising, disruptive, and pioneering solutions across diverse domains in precision medicine for oncology. It brings the most recent and successful and/or high-potential companies to light. The focus has been to identify vendors that bring in the advantage purely in terms of analytics - not other components of data management and meaningful use. These companies create extraordinary value for their internal and external stakeholders by showcasing visionary leadership and implementing industry best practices, and through business model innovation.

Precision medicine for oncology is defined as patient-specific cancer care that is aided by a targeted software suite. The realm of precision medicine is determined by providers' willingness and ability to capture and normalize disparate patient data - including clinical, socioeconomic, behavioral, and genomic - to identify evidence-based treatments that are ideal for each patient.

Despite the low levels of supply-side maturity, more providers will embrace precision medicine, especially in the United States, to improve patient outcomes and rationalize corporate profitability due to mandatory or voluntary involvement in value-based care and the Precision Medicine Initiative. They will depend on external specialist firms to develop proprietary tools or introduce third-party platforms.

Precision medicine IT vendors are going to leverage this renewed market interest to facilitate visionary patient services, supported by the latest clinical and academic evidence.

Top vendors will digitize and automate the process of patient data capture, analysis, and reporting. They will help generate patient-specific treatment options and recommend potential recovery plans based on each patients clinical and genomic profiles. Physicians will be able to validate these auto-generated clinical pathways based on their experience and knowledge.

Key Topics Covered:

1. Executive Summary

• Global Precision Medicine IT Market Snapshot
• Global Precision Medicine IT Solutions for Oncology-Analysis of Companies to Action
• Strategic Imperatives for Industry Stakeholders to Explore Precision Medicine
• Precision Medicine-Regional Market Overview
• Key Questions this Study will Answer
• Precision Medicine-Future Impact on Healthcare
• Precision Medicine-Strategic Imperatives for Success and Growth

2. Companies to Action Overview

• Industry Convergence Driving Disruption and Innovation
• Convergence in Healthcare Creates Both Opportunities and Threats
• Companies to Action Have the Potential to Disrupt Current Healthcare Industry Paradigms

3. Digital Health Industry Snapshot

• Digital Health Benefits from Broader Industry Convergence
• Digital Health Priorities
• Digital Health Market Segmentation and Convergence

4. Precision Medicine for Oncology Market Overview

• What is Precision Medicine?
• Market Challenges, Opportunities, and Concerns
• Current State of Precision Medicine Adoption
• Key Data Sources for Precision Medicine
• Impact of Precision Medicine on Oncology
• Impact of Key Market Influencers
• Operational Architecture of Precision Medicine for Oncology
• Operational Architecture of Precision Medicine for Oncology Explained
• Stakeholders' Digital Health Solutions
• Digital Health Solutions Applicable Across the Care Continuum
• Digital Health Companies Supporting Precision Medicine for Oncology-Vendor Landscape
• Digital Health Companies Supporting Precision Medicine for Oncology-Vendor Landscape Discussion
• Top Industry Needs and Vendor Strategies
• Precision Medicine IT Solutions for Oncology-C2A Key Findings

5. C2A Profiles

• 2bPrecise (Allscripts)
• Cerner
• GenomOncology
• IBM Watson Health
• N-of-One
• NantHealth
• Navican (an Intermountain Healthcare Company)
• Quest Diagnostics
• Royal Philips
• Via Oncology

6. The Last Word

• Precision Medicine-Future Impact on Healthcare
• Precision Medicine-Strategic Imperatives for Success and Growth
• Legal Disclaimer

7. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/rvllch/global_precision?w=12

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Genomics, Oncology